17 Apr 2026Open access
Docosahexaenoic acid is comparable to vildagliptin in improving hyperglycemia and pancreatic insulin signaling of diabetic rats via SIRT1/Akt/PI3K pathwayPublisher siteScientific Reports, Sirtuins and Resveratrol in Medicine
UniversitiesNaglaa F. Khedr
Active, last published 2026
In cancer, lipids, and metabolism
Naglaa F.
Khedr
Scholar“Research focused on Cancer, Lipids, and Metabolism and adjacent fields.”
Tanta University
Claim Your Profile17
H-index
812
Citations
Naglaa has not officially claimed their profile. If you are Naglaa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aglaa F. Khedr is a researcher working on Cancer, Lipids, and Metabolism. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Naglaa's work has been cited 812 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cancer, Lipids, and Metabolism×6Autophagy in Disease and Therapy×4Diabetes Treatment and Management×3Drug Transport and Resistance Mechanisms×3Sirtuins and Resveratrol in Medicine×3
04 · Where I am
Affiliations
Affiliation on published researchTanta UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works20 Mar 2026Open access
Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cellsPublisher siteMedical Oncology, Cancer, Lipids, and Metabolism
9 Dec 2025Open access3cites
Fisetin Mitigates Ferroptosis and Promotes Remyelination in a Cuprizone Model of Multiple SclerosisPublisher siteJournal of Neuroimmune Pharmacology, Ferroptosis and cancer prognosis
10 Oct 20252cites
Comparative effects of empagliflozin and vildagliptin on inflammation and atrial function in patients with type 2 diabetes and coronary artery disease: EMPA-VILDA-Response trialPublisher siteEuropean Journal of Pharmacology, Diabetes Treatment and Management
25 Jun 20253cites
Berberine‐Induced Cytotoxicity in Breast Cancer Is Mediated by Reversal of EMT and Repression of Sirtuin 1/AKT Signaling PathwaysPublisher siteJournal of Biochemical and Molecular Toxicology, Berberine and alkaloids research
23 May 20252cites
Diagnostic and Prognostic Roles of Inflammatory Biomarkers in Patients With Coronary Heart Disease and Heart Failure Treated With EmpagliflozinPublisher siteClinical Therapeutics, Diabetes Treatment and Management
19 May 2025Open access2cites
Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitisPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Liver Disease Diagnosis and Treatment
28 Oct 2024Open access1cites
Effect of green coffee on miR-133a, miR-155 and inflammatory biomarkers in obese individualsPublisher siteDiabetology & Metabolic Syndrome, Coffee research and impacts
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Naglaa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you